ocular hypertension_Tg(CMV-MYOC*Y437H)#Vcs/0

http://metadb.riken.jp/0005258IC57BL6JSJLJTgCMVMYOCY437HVcs0TgCMVMYOCY437HVcs

ocular hypertension_Tg(CMV-MYOC*Y437H)#Vcs/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion, Val C Sheffield
  http://metadb.riken.jp/db/mgi_rdf/MGI:5302111

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(CMV-MYOC*Y437H)#Vcs/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(CMV-MYOC*Y437H)#Vcs

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6J * SJL/J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• ocular hypertension
  http://purl.obolibrary.org/obo/MP_0005258

文献

http://purl.org/net/cito/citesAsAuthority

• Gulab S. Zode, et.al., Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma., The Journal of clinical investigation, 2011, 121
  http://rdf.ncbi.nlm.nih.gov/pubmed/21821918